Author:
Erfanian Saiedeh,Mir Hamed,Abdoli Amir,Roustazadeh Abazar
Abstract
Abstract
Introduction
Gastric inhibitory polypeptide receptor (GIPR) encodes a G-protein coupled receptor for gastric inhibitory polypeptide (GIP), which was demonstrated to stimulate insulin secretion. Relation of GIPR gene variation to impaired insulin response has been suggested in previous studies. However, little information is available regarding GIPR polymorphisms and type 2 diabetes mellitus (T2DM). Hence, the aim of the study was to investigate single nucleotide polymorphisms (SNPs) in the promoter and coding regions of GIPR in Iranian T2DM patients.
Materials and methods
Two hundred subjects including 100 healthy and 100 T2DM patients were recruited in the study. Genotypes and allele frequency of rs34125392, rs4380143 and rs1800437 in the promoter, 5ʹ UTR and coding region of GIPR were investigated by RFLP-PCR and Nested-PCR.
Results
Our finding indicated that rs34125392 genotype distribution was statistically different between T2DM and healthy groups (P = 0.043). In addition, distribution of T/- + -/- versus TT was significantly different between the both groups (P = 0.021). Moreover, rs34125392 T/- genotype increased the risk of T2DM (OR = 2.68, 95%CI = 1.203–5.653, P = 0.015). However, allele frequency and genotype distributions of rs4380143 and rs1800437 were not statistically different between the groups (P > 0.05). Multivariate analysis showed that the tested polymorphisms had no effect on biochemical variables.
Conclusion
We concluded that GIPR gene polymorphism is associated with T2DM. In addition; rs34125392 heterozygote genotype may increase the risk of T2DM. More studies with large sample size in other populations are recommended to show the ethnical relation of these polymorphisms to T2DM.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference27 articles.
1. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet (London, England). 2017 Jun 3;389(10085):2239-51. PubMed PMID: 28190580. Epub 2017/02/14. eng.
2. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al. Pathophysiology of Type 2 Diabetes Mellitus. International journal of molecular sciences. 2020 Aug 30;21(17). PubMed PMID: 32872570. Pubmed Central PMCID: PMC7503727. Epub 2020/09/03. eng.
3. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. The New England journal of medicine. 2001 Sep 13;345(11):790-7. PubMed PMID: 11556298. Epub 2001/09/15. eng.
4. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Annals of internal medicine. 2013 Oct 15;159(8):543–51. PubMed PMID: 24126648. Epub 2013/10/16. eng.
5. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segrè AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012 Sep;44(9):981–90. PubMed PMID: 22885922. Pubmed Central PMCID: PMC3442244. Epub 2012/08/14. eng.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献